Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
作者信息
Iacoboni Gloria, Rejeski Kai, Villacampa Guillermo, van Doesum Jaap A, Chiappella Annalisa, Bonifazi Francesca, Lopez-Corral Lucia, van Aalderen Michiel, Kwon Mi, Martínez-Cibrian Nuria, Bramanti Stefania, Reguera-Ortega Juan Luis, Camacho-Arteaga Lina, Schmidt Christian, Marín-Niebla Ana, Kersten Marie José, Martin Garcia-Sancho Alejandro, Zinzani Pier Luigi, Corradini Paolo, van Meerten Tom, Subklewe Marion, Barba Pere
机构信息
Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
出版信息
Blood Adv. 2022 Jun 28;6(12):3606-3610. doi: 10.1182/bloodadvances.2021006922.
Abstract
摘要
Zotero 插件